Literature DB >> 20196882

Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey.

Rachel M Taliercio1, Robert L Chatburn, James K Stoller.   

Abstract

BACKGROUND: Alpha-1 antitrypsin deficiency is a common genetic condition that predisposes to emphysema and liver disease. Alpha-1 antitrypsin deficiency is under-recognized, so affected individuals often experience long delays in diagnosis and visits to multiple physicians before correct diagnosis. Reasoning that inadequate knowledge about alpha-1 antitrypsin deficiency could contribute to this under-recognition, we designed this study to evaluate internal medicine house officers' and respiratory therapists' (RTs) knowledge of alpha-1 antitrypsin deficiency.
METHODS: We evaluated knowledge of alpha-1 antitrypsin deficiency with a Web-based test containing 30 multiple-choice questions. Invitations to take the test were sent via e-mail to all internal medicine house officers and RTs at The Cleveland Clinic main campus hospital. We assessed test scores by profession, years of training/experience, and self-assessed knowledge of alpha-1 antitrypsin deficiency.
RESULTS: Of 332 invitees, 202 (61%) responded, of whom 165 (50%) provided complete responses (99 RTs, 66 physicians). The mean scores (percent of correct answers) were 54% and 52% for physicians and RTs, respectively (P = .25). The scores did not differ among the physicians when examined by subspecialty (pulmonary/critical care vs other) or post-graduate education level (P = .94). RTs who had graduated from a 4-year respiratory therapy program had a higher mean score than those who had graduated from a 2-year program (56% vs 50%, P = .02). Respondents' whose self-assessment of their knowledge about alpha-1 antitrypsin deficiency was "somewhat knowledgeable" had higher test scores than any other self-assessed knowledge level, regardless of profession.
CONCLUSIONS: These results indicate a generally low level of knowledge about alpha-1 antitrypsin deficiency among physicians and RTs. Causes of under-recognition of alpha-1 antitrypsin deficiency, including the possibility of poor knowledge as a contributor, warrant further study.

Entities:  

Mesh:

Year:  2010        PMID: 20196882

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  8 in total

1.  Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.

Authors:  James K Stoller; Loutfi S Aboussouan; Richard E Kanner; Laura A Wilson; Phil Diaz; Robert Wise
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 2.  Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Authors:  Timm Greulich; Claus F Vogelmeier
Journal:  Ther Adv Respir Dis       Date:  2015-09-04       Impact factor: 4.031

3.  Diagnosis of alpha-1 antitrypsin deficiency: a population-based study.

Authors:  Miriam Barrecheguren; Mónica Monteagudo; Pere Simonet; Carl Llor; Esther Rodriguez; Jaume Ferrer; Cristina Esquinas; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-10

4.  Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.

Authors:  Florian M Karl; Rolf Holle; Robert Bals; Timm Greulich; Rudolf A Jörres; Annika Karch; Armin Koch; Stefan Karrasch; Reiner Leidl; Holger Schulz; Claus Vogelmeier; Margarethe E Wacker
Journal:  Respir Res       Date:  2017-04-17

5.  Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.

Authors:  Myriam Calle Rubio; Joan B Soriano; José Luis López-Campos; Juan J Soler-Cataluña; Bernardino Alcázar Navarrete; José Miguel Rodríguez González-Moro; Marc Miravitlles; Miriam Barrecheguren; Manuel E Fuentes Ferrer; Juan Luis Rodriguez Hermosa
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

6.  Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood.

Authors:  Henry C Lin; Nagraj Kasi; J Antonio Quiros
Journal:  Curr Pediatr Rev       Date:  2019

Review 7.  Detection of alpha-1 antitrypsin deficiency: the past, present and future.

Authors:  Mark Brantly; Michael Campos; Angela M Davis; Jeanine D'Armiento; Kenneth Goodman; Kathi Hanna; Miriam O'Day; John Queenan; Robert Sandhaus; James Stoller; Charlie Strange; Jeffrey Teckman; Adam Wanner
Journal:  Orphanet J Rare Dis       Date:  2020-04-19       Impact factor: 4.123

8.  Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.

Authors:  Irene Belmonte; Alexa Nuñez; Miriam Barrecheguren; Cristina Esquinas; Mònica Pons; Rosa M López-Martínez; Gerard Ruiz; Albert Blanco-Grau; Roser Ferrer; Joan Genescà; Marc Miravitlles; Francisco Rodríguez-Frías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.